- Home
- SER vs PASG Comparison
SER vs PASG Comparison
Compare SER & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SER
- PASG
- Stock Information
- Founded
- SER 2017
- PASG 2017
- Country
- SER United States
- PASG United States
- Employees
- SER N/A
- PASG N/A
- Industry
- SER Biotechnology: Pharmaceutical Preparations
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- SER Health Care
- PASG Health Care
- Exchange
- SER Nasdaq
- PASG Nasdaq
- Market Cap
- SER 45.2M
- PASG 42.2M
- IPO Year
- SER 2018
- PASG 2020
- Fundamental
- Price
- SER $4.81
- PASG $0.60
- Analyst Decision
- SER
- PASG Strong Buy
- Analyst Count
- SER 0
- PASG 3
- Target Price
- SER N/A
- PASG $8.00
- AVG Volume (30 Days)
- SER 31.9K
- PASG 886.7K
- Earning Date
- SER 11-12-2024
- PASG 03-03-2025
- Dividend Yield
- SER N/A
- PASG N/A
- EPS Growth
- SER N/A
- PASG N/A
- EPS
- SER N/A
- PASG N/A
- Revenue
- SER $3,157,500.00
- PASG N/A
- Revenue This Year
- SER N/A
- PASG N/A
- Revenue Next Year
- SER N/A
- PASG N/A
- P/E Ratio
- SER N/A
- PASG N/A
- Revenue Growth
- SER 2454.55
- PASG N/A
- 52 Week Low
- SER $3.81
- PASG $0.45
- 52 Week High
- SER $19.93
- PASG $1.79
- Technical
- Relative Strength Index (RSI)
- SER 46.26
- PASG 43.68
- Support Level
- SER $4.70
- PASG $0.56
- Resistance Level
- SER $5.40
- PASG $0.64
- Average True Range (ATR)
- SER 0.49
- PASG 0.11
- MACD
- SER -0.01
- PASG -0.01
- Stochastic Oscillator
- SER 11.93
- PASG 8.69
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.